The central hypothesis we explored here is that JARID1B facilitates the generation and maintenance of cancer stem cells (CSCs) in NB tumors, contrary to the findings of Schmitz and coworkers implicating JARID1B in CSC differentiation. The gene discussed is KDM5B; the disease is neuroblastoma.